Aquestive therapeutics reports fourth quarter & full year 2022 financial results and provides business update on key 2023 objectives

Warren, n.j., march 07, 2023 (globe newswire) -- aquestive therapeutics, inc. (nasdaq:aqst), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, today reported financial results for the fourth quarter and full year ended december 31, 2022, and provided a progress update on the key 2023 objectives previously outlined by the company.
AQST Ratings Summary
AQST Quant Ranking